Search
for
Sort by
Research 31–60 of 40
- Effects of oxytocin on the hair growth ability of dermal papilla cells
- Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
- Androgenetic alopecia – Update 2022
- Drug-induced scarring and permanent alopecia
- 28-Year-Old Female with Diffuse Thinning of the Scalp after Isotretinoin and Oral Contraceptives
- Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies
- Cosmetovigilance studies to assess the safety of cosmetic therapy in hair segments and skin non-laser
- Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth – safety and efficacy evaluation in a first-in-man pilot clinical study
- Bioengineered Exosomal Hair Growth Factors Complex in Upregulating HFDPCs, Downregulating IL-6, IL-1β in Hair Growth
- Determinants of the influence and experiences of cosmetic and aesthetics profiling on interpersonal relationships among Indian patients
- QR 678 & QR678 Neo Vs PRP—A randomised, comparative, prospective study
- QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Effectiveness of QR678 and QR678 Neo <sup>®</sup> with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata –A randomized, comparative, prospective study
- Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo <sup>®</sup> hair regrowth formulation for the treatment of Androgenetic Alopecia—A prospective study
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- Comparison between QR678 neo and platelet rich plasma for hair growth -A retrospective study
- A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®—A prospective pilot study
- “Comparison of QR 678 ® & QR678 ® Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia—Which is better?”
- Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia
- Evaluation of the efficacy of a biomimetic peptide solution for rejuvenation of donor scalp and as storage media for hair follicle grafts during FUE hair transplantation
- Evolution and Trends of Facial Plastic Surgery and Facial Aesthetic Procedures in India: From Awakening to Revival
- “Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults—A systematic review”
- Platelet‐rich plasma for androgenetic alopecia: Efficacy differences between men and women
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis
- Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.